Press Releases

01.05.2015
Ophthotech Corporation to Present at the 33rd Annual J.P. Morgan Healthcare Conference
12.15.2014
Ophthotech Added to NASDAQ Biotechnology Index
12.02.2014
Ophthotech Corporation to Present at the Oppenheimer 25th Annual Healthcare Conference
11.13.2014
Ophthotech Corporation to Present at the Stifel 2014 Healthcare Conference
11.11.2014
Ophthotech Provides Business Update and Reports Third Quarter 2014 Financial Results
11.04.2014
Ophthotech Corporation to Present at the Credit Suisse 2014 Healthcare Conference
11.03.2014
Ophthotech Corporation to Announce Third Quarter 2014 Financial Results and Host Conference Call on Tuesday, November 11, 2014
10.03.2014
Ophthotech Corporation Names Todd N. Smith as Chief Commercial Officer
09.23.2014
Ophthotech Corporation Names Michael G. Atieh as Executive Vice President and Chief Financial and Business Officer
09.16.2014
Ophthotech Announces Fovista® Phase 2b Independent Analysis Shows that Fovista® Anti-PDGF Therapy, Combined with Anti-VEGF Therapy, is Associated with a Reduction of Sub-retinal Fibrosis in Wet AMD Patients